AMLN Amylin Pharmaceuticals, Inc. (MM)

Amylin Pharmaceuticals to Webcast Corporate Update SAN DIEGO, Dec. 1 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) will webcast a corporate update on Sunday, December 5, 2004 at 7:00 p.m. Pacific Time. Ginger L. Graham, President and Chief Executive Officer of Amylin Pharmaceuticals, and other management team members will provide a corporate overview and updates on the company's development programs. The presentation will be webcast live, and a recording will be made available following the event. The webcast and recording will be accessible through Amylin's corporate website, located at http://www.amylin.com/. To access the live webcast, please log on to Amylin's site approximately fifteen minutes prior to the presentation to register and download any necessary audio software. Amylin Pharmaceuticals is committed to improving the lives of people with diabetes and other metabolic diseases through the discovery, development and commercialization of innovative, cost-effective medicines. DATASOURCE: Amylin Pharmaceuticals, Inc. CONTACT: Mark G. Foletta, Vice President of Finance and Chief Financial Officer of Amylin Pharmaceuticals, Inc., +1-858-552-2200 Web site: http://www.amylin.com/

Copyright